24.2 C
New York

Effective Epithelial Mesothelioma Treatment Options | A Comprehensive Guide


Epithelial mesothelioma is a rare and aggressive cancer that develops in the lining of the chest (pleura), abdomen (peritoneum), or heart (pericardium). It is primarily caused by exposure to asbestos fibers, which can linger in the body for decades before causing cancer. While mesothelioma has traditionally been associated with poor prognosis and limited treatment options, significant advancements in research and technology have emerged in recent years, offering patients hope and improving their quality of life. In this comprehensive guide, we will delve into the various treatment options available for epithelial mesothelioma, their effectiveness, side effects, and the latest research trends. We’ll also examine the importance of early detection, comprehensive patient care, and the ongoing search for new therapies.

Understanding Epithelial Mesothelioma

Before discussing treatment options, it’s crucial to understand the complexities of epithelial mesothelioma. This type of mesothelioma accounts for roughly 60-70% of all cases and is characterized by the growth of abnormal cells in the epithelial tissue, which lines the internal organs. These cells can spread to neighboring tissues and organs, making treatment challenging.

Types of Epithelial Mesothelioma


Epithelial mesothelioma is broadly classified into four subtypes: epithelial, sarcomatoid, biphasic, and desmoplastic. The most common subtype is epithelial, accounting for roughly 60-70% of cases, with a varied prognosis depending on specific factors such as the stage and location of the tumor.

Sarcomatoid mesothelioma is less common, accounting for 10-20% of cases, and is associated with a more aggressive course. It is often characterized by rapid tumor growth and is resistant to traditional treatment methods.

Biphasic mesothelioma is a mixed type that exhibits features of both epithelial and sarcomatoid cells. It accounts for approximately 20-35% of cases and has an intermediate prognosis, dependent on the ratio of epithelial and sarcomatoid cells present.

Desmoplastic mesothelioma is a rare subtype, accounting for only 1% of all mesothelioma cases. It is characterized by the growth of dense scar-like tissue and can be challenging to diagnose as it often presents with symptoms similar to other diseases.

Causes and Risk Factors


Exposure to asbestos is the primary cause of epithelial mesothelioma. Asbestos refers to a group of minerals made up of microscopic fibers that were widely used in construction, insulation, and other industries due to their heat and fire-resistant properties. When these fibers are disturbed, they can become airborne and inhaled, where they can then become trapped in the lining of the lungs or abdomen. Over time, these fibers can damage the cells, leading to the development of mesothelioma.

Other risk factors for epithelial mesothelioma include:

  • Occupations such as mining, milling, manufacturing, and construction where asbestos exposure is common
  • Living in close proximity to asbestos mines or factories
  • Family history of mesothelioma
  • Simultaneous exposure to asbestos and other carcinogens
  • Radiation exposure
  • Genetic predisposition

Traditional Treatment Options

The treatment approach for epithelial mesothelioma typically depends on several factors, including the stage and location of the tumor, the patient’s overall health, and their personal preferences. The goal of treatment is to control the cancer, relieve symptoms, and improve the patient’s quality of life. In some cases, surgery may be curative, while in others, it may be used in combination with other treatments to prolong survival.


Surgery is a standard treatment option for epithelial mesothelioma and may be used in conjunction with other therapies such as chemotherapy and radiation. The type of surgery recommended will depend on the location and size of the tumor.

  • Pleurectomy/decortication (P/D): This surgical procedure involves the removal of the pleura, the thin membrane that lines the lungs, and may also involve removing the lining of the chest wall. It is typically recommended for patients with early-stage mesothelioma or those who are not eligible for more extensive surgeries.
  • Extrapleural pneumonectomy (EPP): This radical surgery involves the removal of the entire affected lung, part of the diaphragm, the lining of the heart, and nearby lymph nodes. It is typically recommended for patients with advanced mesothelioma and is accompanied by a combination of chemotherapy and radiation therapy.
  • Cytoreductive surgery with heated intraoperative chemotherapy (HIPEC): This is a relatively new surgical approach that involves the surgical removal of tumors followed by the infusion of heated chemotherapy directly into the abdominal cavity. It is commonly used to treat peritoneal mesothelioma, and studies have shown promising results in improving patient outcomes.


Chemotherapy involves the use of drugs to kill cancer cells or prevent them from growing and dividing. It may be used as a primary treatment for mesothelioma or in combination with surgery or radiation therapy. Currently, two chemotherapy drugs have been approved by the FDA for treating mesothelioma: pemetrexed (Alimta) and cisplatin. These drugs work by targeting fast-growing cancer cells and can help shrink tumors, relieve symptoms, and improve overall survival.

One of the main challenges with chemotherapy is the systemic side effects it can cause, including fatigue, nausea, hair loss, and lowered immunity. However, advancements in drug delivery techniques, such as intrapleural and intraperitoneal chemotherapy, have shown promising results in improving outcomes while reducing side effects.

Radiation Therapy

Radiation therapy uses high-energy rays to kill cancer cells and shrink tumors. It may be used as a primary treatment for localized mesothelioma or in combination with surgery and/or chemotherapy. The most common type of radiation therapy for mesothelioma is external beam radiation, where a machine directs radiation to the specific area of the body affected by cancer. Another type, called brachytherapy, involves inserting radioactive material directly into the tumor.

While radiation therapy can be effective in killing cancer cells, it can also cause damage to healthy tissues, leading to side effects such as skin irritation, fatigue, and nausea. However, advancements in technology, such as intensity-modulated radiation therapy (IMRT) and proton therapy, have allowed for more precise targeting of cancer cells, minimizing damage to surrounding tissues.

Emerging Treatment Options

In recent years, there has been significant progress in the development of novel treatments for mesothelioma. These include targeted therapies, immunotherapy, and gene therapy, which are still in the clinical trial phase but have shown promising results in early studies.

Targeted Therapies

Targeted therapies involve the use of drugs that specifically target certain molecules or pathways involved in the growth and survival of cancer cells. Unlike traditional chemotherapy drugs, which can harm both healthy and cancerous cells, targeted therapies aim to minimize the damage to healthy tissues while maximizing their effect on cancer cells. One of the main advantages of targeted therapies is the potential for personalized treatment based on the specific characteristics of a patient’s tumor.

Some examples of targeted therapies currently being studied for mesothelioma include:

  • Bevacizumab (Avastin): This drug works by inhibiting the formation of new blood vessels, which are essential for the growth and spread of tumors. It has shown promising results in combination with chemotherapy for treating advanced mesothelioma.
  • Erlotinib (Tarceva): This targeted therapy drug blocks a specific protein involved in cell growth and division. It has been shown to improve overall survival and progression-free survival when used in combination with chemotherapy for treating advanced mesothelioma.
  • Cetuximab (Erbitux): This targeted therapy drug works by blocking the activity of a protein responsible for promoting cell growth and is currently being studied in clinical trials for mesothelioma.


Immunotherapy involves using the body’s immune system to fight cancer. It works by boosting the body’s natural defenses or by helping the immune system recognize and attack cancer cells more effectively. While still in its early stages for mesothelioma, several types of immunotherapy, such as checkpoint inhibitors, cancer vaccines, and adoptive cell transfer, have shown promising results in clinical trials.

Gene Therapy

Gene therapy is an emerging treatment approach that involves using genes to treat or prevent diseases, including cancer. The basic idea behind gene therapy is to use a virus or another delivery system to introduce a healthy gene into cancer cells, replacing the faulty gene that is causing the cells to grow uncontrollably. While gene therapy for mesothelioma is still in its early stages, it holds great potential for future treatments.

Clinical Trials and Research

Clinical trials play a vital role in advancing the treatment of mesothelioma by providing access to cutting-edge therapies and contributing to a better understanding of the disease and its treatment. Researchers are continually exploring new treatment approaches and combinations of existing treatments to improve patient outcomes.

One example of ongoing research is the study of mesothelioma biomarkers, which are substances present in the blood, tissue, or other bodily fluids that can indicate the presence or progression of the disease. Identifying these biomarkers can help in the early detection and monitoring of mesothelioma, allowing for earlier treatment intervention.

Researchers are also exploring the use of artificial intelligence (AI) and machine learning to improve the accuracy of mesothelioma diagnosis and predict patient outcomes. By analyzing large amounts of data, AI can assist in identifying patterns and trends that may be missed by human observers, leading to more precise and personalized treatment plans.

Palliative Care and Support

While there is currently no cure for mesothelioma, palliative care and support play a crucial role in improving the quality of life for patients with this disease. Palliative care involves addressing the physical, emotional, and spiritual needs of the patient while they undergo treatment. This includes managing symptoms and side effects, providing pain relief, and addressing psychological and social concerns.

Support groups and counseling are also essential for patients and their families facing a mesothelioma diagnosis. These resources provide a safe space for individuals to share their experiences, receive emotional support, and learn coping strategies from others in similar situations.


In conclusion, while epithelial mesothelioma remains a rare and aggressive cancer, significant advancements in treatment options have emerged in recent years, offering hope for patients and improving their quality of life. Effective treatment is dependent on early detection, comprehensive patient care, and ongoing research to develop new therapies and improve existing ones. With continued efforts and collaboration between researchers, healthcare providers, and patients, we can move closer to finding a cure for this devastating disease.

Related articles

Recent articles